July 26, 2024Open Access

Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The authors report the prospective evaluation of reduced dose alkylator chemotherapy combined with radiotherapy for European Pediatric Soft Tissue Sarcoma Study Group (EpSSG) standard risk nonalveolar rhabdomyosarcoma (NA-RMS).

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo

Cite This Study

Mandeville et al. (Fri,) studied this question.

synapsesocial.com/papers/68e5ee7cb6db643587582aba https://doi.org/https://doi.org/10.1002/cncr.35497

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study2014 · 324 citations
2Treatment of soft tissue sarcoma in childhood and adolescence: A report of the german cooperative soft tissue sarcoma study1992 · 137 citations
3Survival of children with soft-tissue sarcoma in Europe since 19782001 · 112 citations
4Treatment of Orbital Rhabdomyosarcoma: Survival and Late Effects of Treatment—Results of an International Workshop2001 · 187 citations
5Introducing INSTRuCT: An international effort to promote cooperation and data sharing2020 · 32 citations

Me gusta

Guardar

Ver artículo completo